Copyright
©The Author(s) 2024.
World J Cardiol. Feb 26, 2024; 16(2): 54-57
Published online Feb 26, 2024. doi: 10.4330/wjc.v16.i2.54
Published online Feb 26, 2024. doi: 10.4330/wjc.v16.i2.54
Pre-procedural risk factors | Age, yr | Male sex | Prior MI | DM | Risk ratio | Ref. |
Prior conduction defect | [2-5,15] | |||||
RBBB | 80-85 | 43%-52% | 25%-45% | 29%-37% | 2.50-3.10 | |
Mobitz type 1 AV block | 3.10 | |||||
Left anterior hemiblock | 1.20-1.40 | |||||
Bifascicular block | 2.40-2.60 | |||||
Peri-procedural AV block | Meta-analysis of 75 cohort studies[5] | 4.17 | [5] | |||
Age ≥ 80 yr | Meta-analysis of 75 cohort studies[5]; meta-analysis of 239 cohort studies[15] | 1.07-1.19 | [2,5,15] | |||
Self-expanding valve | Meta-analysis of 32 clinical trials[4]; meta-analysis of 239 cohort studies[15] | 1.94-7.56 | [2,4,5] | |||
Aortic valve area < 0.75 cm2 | 84 | 52.0% | 26.4% | 36.4% | 1.21 | [2] |
≥ Moderate operative risk | 84 | 52.0% | 26.4% | 36.4% | 1.85 | [2] |
Atrial fibrillation | Meta-analysis of 75 cohort studies[5]; meta-analysis of 239 cohort studies[15] | 1.05-1.10 | [5,15] |
- Citation: Lin GM, Huang WC, Han CL. Current knowledge for the risk factors of early permanent pacemaker implantation following transcatheter aortic valve replacement and what is next for the primary prevention? World J Cardiol 2024; 16(2): 54-57
- URL: https://www.wjgnet.com/1949-8462/full/v16/i2/54.htm
- DOI: https://dx.doi.org/10.4330/wjc.v16.i2.54